Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.49 USD | +4.97% | +3.58% | -14.88% |
04-16 | Foghorn Therapeutics Names Kristian Humer CFO | MT |
04-16 | Foghorn Therapeutics Inc. Appoints Kristian Humer as Chief Financial Officer | CI |
Sales 2024 * | 35.28M 2.82B | Sales 2025 * | 37.33M 2.99B | Capitalization | 234M 18.71B |
---|---|---|---|---|---|
Net income 2024 * | -247M -19.77B | Net income 2025 * | -221M -17.69B | EV / Sales 2024 * | 3.89 x |
Net cash position 2024 * | 96.34M 7.71B | Net cash position 2025 * | 227M 18.21B | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 * |
-1.36
x | P/E ratio 2025 * |
-2.15
x | Employees | 116 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.21% |
Latest transcript on Foghorn Therapeutics Inc.
1 day | +4.97% | ||
1 week | +3.58% | ||
Current month | -18.18% | ||
1 month | -9.56% | ||
3 months | +80.00% | ||
6 months | +75.96% | ||
Current year | -14.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 30/04/17 | |
Douglas Cole
FOU | Founder | 63 | 30/09/15 |
Fanny Cavalié
COO | Chief Operating Officer | 46 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Simba Gill
BRD | Director/Board Member | 60 | 30/06/17 |
Douglas Cole
FOU | Founder | 63 | 30/09/15 |
B. Parshall
BRD | Director/Board Member | 69 | 15/08/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 5.49 | +4.97% | 35,367 |
25/04/24 | 5.23 | +0.38% | 48,749 |
24/04/24 | 5.21 | +0.97% | 111,333 |
23/04/24 | 5.16 | +2.18% | 45,759 |
22/04/24 | 5.05 | -4.72% | 77,557 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.88% | 234M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- FHTX Stock